Ontario recommends only the Pfizer-BioNTech (Comirnaty) vaccine be used in the 18 to 24-year-old age group due to a rare symptom caused by the Moderna (Spikevax) vaccine.
Ontario recommends only the Pfizer-BioNTech (Comirnaty) vaccine be used in the 18 to 24-year-old age group due to a rare symptom caused by the Moderna (Spikevax) vaccine.
Fully vaccinated Quebec residents who received the AstraZeneca COVID-19 vaccine or mix-and-match doses will have the option to get a third shot of either Pfizer or Moderna.
Moderna will be the vaccine of choice for Ontarians in Toronto and Peel Region this week due to a decrease in the supply of Pfizer vaccines.
Canada is receiving a shipment of one million Moderna vaccine doses a week earlier than expected.
In the last four years, Health Canada has approved more than 1,500 new or updated pharmaceuticals.
Ontario says it expects to receive approximately 53,000 doses of the newly approved Moderna COVID-19 vaccine by the end this month.